Dr. Helen Thackray, MD

NPI: 1912082025
Total Payments
$4.6M
2024 Payments
$4.0M
Companies
3
Transactions
36

Payment Breakdown by Category

Other$4.5M (99.8%)
Travel$5,652 (0.1%)
Food & Beverage$1,308 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Acquisitions $4.0M 1 86.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $588,150 11 12.9%
Travel and Lodging $5,652 12 0.1%
Food and Beverage $1,308 12 0.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $4.0M 2 $0 (2024)
ImmunoGen, Inc. $543,948 19 $0 (2024)
BioCryst Pharmaceuticals, Inc. $44,238 15 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $4.0M 3 ABBVIE INC. ($4.0M)
2023 $536,448 18 ImmunoGen, Inc. ($536,448)
2020 $44,238 15 BioCryst Pharmaceuticals, Inc. ($44,238)

All Payment Transactions

36 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
03/20/2024 ABBVIE INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $6,923.00 General
02/14/2024 ABBVIE INC. Acquisitions Cash or cash equivalent $3,961,151.84 General
01/03/2024 ImmunoGen, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,500.00 General
10/03/2023 ImmunoGen, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,500.00 General
09/30/2023 ImmunoGen, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Stock, stock option, or any other ownership interest $7,490.64 General
09/12/2023 ImmunoGen, Inc. Travel and Lodging In-kind items and services $489.00 General
09/12/2023 ImmunoGen, Inc. Food and Beverage In-kind items and services $179.15 General
09/12/2023 ImmunoGen, Inc. Food and Beverage In-kind items and services $54.11 General
09/12/2023 ImmunoGen, Inc. Food and Beverage In-kind items and services $31.75 General
07/05/2023 ImmunoGen, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,500.00 General
06/30/2023 ImmunoGen, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Stock, stock option, or any other ownership interest $7,491.39 General
06/14/2023 ImmunoGen, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Dividend, profit or other return on investment $270,539.86 General
06/14/2023 ImmunoGen, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Stock, stock option, or any other ownership interest $231,954.80 General
06/13/2023 ImmunoGen, Inc. Travel and Lodging In-kind items and services $1,128.83 General
06/13/2023 ImmunoGen, Inc. Food and Beverage In-kind items and services $332.30 General
06/13/2023 ImmunoGen, Inc. Food and Beverage In-kind items and services $95.24 General
06/13/2023 ImmunoGen, Inc. Food and Beverage In-kind items and services $52.02 General
06/12/2023 ImmunoGen, Inc. Travel and Lodging In-kind items and services $1,128.83 General
06/12/2023 ImmunoGen, Inc. Food and Beverage In-kind items and services $332.30 General
06/12/2023 ImmunoGen, Inc. Food and Beverage In-kind items and services $95.24 General
06/12/2023 ImmunoGen, Inc. Food and Beverage In-kind items and services $52.20 General
09/02/2020 BioCryst Pharmaceuticals, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $13,750.00 General
06/03/2020 BioCryst Pharmaceuticals, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $13,750.00 General
06/02/2020 BioCryst Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $1,510.80 General
04/16/2020 BioCryst Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $278.08 General

About Dr. Helen Thackray, MD

Dr. Helen Thackray, MD is a Pediatrics healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912082025.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Helen Thackray, MD has received a total of $4.6M in payments from pharmaceutical and medical device companies, with $4.0M received in 2024. These payments were reported across 36 transactions from 3 companies. The most common payment nature is "Acquisitions" ($4.0M).

Practice Information

  • Specialty Pediatrics
  • Location Washington, DC
  • Active Since 10/26/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1912082025

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Washington